Advertisement
Letter to the Editor| Volume 68, ISSUE 4, P860-862, April 2018

Download started.

Ok

Reply to: “The PNPLA3 SNP rs738409:G allele is associated with increased liver disease-associated mortality but reduced overall mortality in a population-based cohort”

Published:December 11, 2017DOI:https://doi.org/10.1016/j.jhep.2017.12.005
      We thank Meffert and co-workers
      • Meffert P.J.
      • Repp K.D.
      • Völzke H.
      • Weiss F.U.
      • Homuth G.
      • Kühn J.P.
      The PNPLA3 SNP rs738409:G allele is associated with increased liver disease-associated mortality but reduced overall mortality in a population based cohort.
      for their interest in our study and for providing data which support our finding of an association between carriage of rs738409:G in patatin-like phospholipase domain-containing 3 (PNPLA3) and the risk of liver-associated mortality, at least in men.
      • Atkinson S.R.
      • Way M.J.
      • McQuillin A.
      • Morgan M.Y.
      • Thursz M.R.
      Homozygosity for rs738409: G in PNPLA3 is associated with increased mortality following an episode of severe alcoholic hepatitis.
      The authors evaluated the association of rs738409:G with mortality in adults participating in a population-based health study in Pomerania. The included population of 4,081 was sub-classified by sex and by the absence/presence of hepatic steatosis on ultrasound. Participants were censored at death or when lost to follow-up with the length of follow-up defined as birth to censorship. The median follow-up period was 11.3 (interquartile range: 10.6–11.8) years, though this is difficult to equate with the definition of the follow-up period provided. In men, carriage of rs738409:G was associated with a fourfold increase in the hazard of liver-disease-related mortality; there were too few events in women for analysis. These data corroborate not only our findings that carriage of rs738409:G is a negative risk factor for survival,
      • Atkinson S.R.
      • Way M.J.
      • McQuillin A.
      • Morgan M.Y.
      • Thursz M.R.
      Homozygosity for rs738409: G in PNPLA3 is associated with increased mortality following an episode of severe alcoholic hepatitis.
      but also the reported association with a reduction in survival in people listed for liver transplantation
      • Friedrich K.
      • Wannhoff A.
      • Kattner S.
      • Brune M.
      • Hov J.R.
      • Weiss K.H.
      • et al.
      PNPLA3 in end-stage liver disease: alcohol consumption, hepatocellular carcinoma development, and transplantation-free survival.
      and in those with cirrhosis and hepatocellular carcinoma.
      • Valenti L.
      • Motta B.M.
      • Soardo G.
      • Iavarone M.
      • Donati B.
      • Sangiovanni A.
      • et al.
      PNPLA3 I148M polymorphism, clinical presentation, and survival in patients with hepatocellular carcinoma.
      The authors also showed that, in men, carriage of rs738409:G was associated with a decrease in the risk of death from coronary artery disease; there was no such effect in women.
      • Meffert P.J.
      • Repp K.D.
      • Völzke H.
      • Weiss F.U.
      • Homuth G.
      • Kühn J.P.
      The PNPLA3 SNP rs738409:G allele is associated with increased liver disease-associated mortality but reduced overall mortality in a population based cohort.
      Liu and colleagues
      • Liu D.J.
      • Peloso G.M.
      • Yu H.
      • Butterworth A.S.
      • Wang X.
      • Mahajan A.
      • et al.
      Exome-wide association study of plasma lipids in >300,000 individuals.
      recently reported in an exome-wide association study in >300,000 individuals that carriage of rs738409:G was associated with a lower risk of coronary artery disease, corroborating this finding, although sex-specific data were not provided.

      Keywords

      Linked Article

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Hepatology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Meffert P.J.
        • Repp K.D.
        • Völzke H.
        • Weiss F.U.
        • Homuth G.
        • Kühn J.P.
        The PNPLA3 SNP rs738409:G allele is associated with increased liver disease-associated mortality but reduced overall mortality in a population based cohort.
        J Hepatol. 2018; 68: 858-860
        • Atkinson S.R.
        • Way M.J.
        • McQuillin A.
        • Morgan M.Y.
        • Thursz M.R.
        Homozygosity for rs738409: G in PNPLA3 is associated with increased mortality following an episode of severe alcoholic hepatitis.
        J Hepatol. 2017; 67: 120-127
        • Friedrich K.
        • Wannhoff A.
        • Kattner S.
        • Brune M.
        • Hov J.R.
        • Weiss K.H.
        • et al.
        PNPLA3 in end-stage liver disease: alcohol consumption, hepatocellular carcinoma development, and transplantation-free survival.
        J Gastroenterol Hepatol. 2014; 29: 1477-1484
        • Valenti L.
        • Motta B.M.
        • Soardo G.
        • Iavarone M.
        • Donati B.
        • Sangiovanni A.
        • et al.
        PNPLA3 I148M polymorphism, clinical presentation, and survival in patients with hepatocellular carcinoma.
        PLoS One. 2013; 8: e75982
        • Liu D.J.
        • Peloso G.M.
        • Yu H.
        • Butterworth A.S.
        • Wang X.
        • Mahajan A.
        • et al.
        Exome-wide association study of plasma lipids in >300,000 individuals.
        Nat Genet. 2017; https://doi.org/10.1038/ng.3977
        • Thursz M.R.
        • Richardson P.
        • Allison M.
        • Austin A.
        • Bowers M.
        • Day C.P.
        • et al.
        Prednisolone or pentoxifylline for alcoholic hepatitis.
        N Engl J Med. 2015; 372: 1619-1628
        • Schlichting P.
        • Christensen E.
        • Andersen P.K.
        • Fauerholdt L.
        • Juhl E.
        • Poulsen H.
        • et al.
        Prognostic factors in cirrhosis identified by Cox's regression model.
        Hepatology. 1983; 3: 889-895
        • D'Amico G.
        • Morabito A.
        • Pagliaro L.
        • Marubini E.
        Survival and prognostic indicators in compensated and decompensated cirrhosis.
        Dig Dis Sci. 1986; 31: 468-475
        • Ginés P.
        • Quintero E.
        • Arroyo V.
        • Terés J.
        • Bruguera M.
        • Rimola A.
        • et al.
        Compensated cirrhosis: natural history and prognostic factors.
        Hepatology. 1987; 7: 122-128
        • Deleuran T.
        • Vilstrup H.
        • Jepsen P.
        Decreasing mortality among Danish alcoholic cirrhosis patients: a nationwide cohort study.
        Am J Gastroenterol. 2016; 111: 817-822
        • Merli M.
        • Riggio O.
        • Dally L.
        Does malnutrition affect survival in cirrhosis? PINC (Policentrica Italiana Nutrizione Cirrosi).
        Hepatology. 1996; 23: 1041-1046
        • Morgan M.Y.
        • Madden A.M.
        • Soulsby C.T.
        • Morris R.W.
        Derivation and validation of a new global method for assessing nutritional status in patients with cirrhosis.
        Hepatology. 2006; 44: 823-835
        • Silander K.
        • Alanne M.
        • Kristiansson K.
        • Saarela O.
        • Ripatti S.
        • Auro K.
        • et al.
        Gender differences in genetic risk profiles for cardiovascular disease.
        PLoS One. 2008; 3: e3615